Universal CAR T-Cell Therapy Helped Treat ALL in Two Infants

Share this content:
Universal CAR T-Cell Therapy Helped Treat ALL in Two Infants
Universal CAR T-Cell Therapy Helped Treat ALL in Two Infants

THURSDAY, Jan. 26, 2017 (HealthDay News) -- Two infants with B-cell acute lymphoblastic leukemia (ALL) are in remission after treatment with genetically modified immune system cells, according to a report on the two cases published in the Jan. 25 issue of Science Translational Medicine.

Waseem Qasim, M.D., Ph.D., a professor of cell and gene therapy at University College London, and colleagues used cells from a healthy donor, then genetically fine-tuned them to be universal chimeric antigen receptor T cells. The cells were altered both to fight the infants' ALL and to minimize the risk of graft-versus-host disease. After receiving the T-cell therapy, one baby did develop graft-versus-host disease. But it was limited to the skin and responded to treatment, according to the study authors.

Both infants went into remission within 28 days of receiving their T-cell infusion. From there, both were able to undergo chemotherapy and a bone marrow transplant. According to Qasim, the babies have remained leukemia-free for 10 and 16 months, and are being closely monitored.

"Having cells premanufactured and ready to use would have obvious advantages in terms of scheduling and coordinating with other treatments," Qasim told HealthDay. Small trials are under way, he added, to see if the therapy can be more widely applied.

Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Low-Dose Hyaluronidase Can Remove Hyaluronic Acid Fillers

Low-Dose Hyaluronidase Can Remove Hyaluronic Acid Fillers

Greater resolution of nodules with hyaluronidase versus saline; more rapid resolution with higher doses

Improvement in Race-Based Disparities in Years of Life Lost

Improvement in Race-Based Disparities in Years of Life ...

Decline in race-based disparities in years of life lost seen in the United States from 1990 to 2014

Drug-Related Endocarditis Cases Up From 2007 to 2015

Drug-Related Endocarditis Cases Up From 2007 to 2015

Increase in endocarditis over nine-year study period mirrored increase in concomitant mixed drug use

is free, fast, and customized just for you!

Already a member?

Sign In Now »